Skip to content

Diet optimization for patients suffering from celiac disease - NutriMATCH-celiac

Diet optimization for patients suffering from celiac disease - NutriMATCH-celiac - Nutri-MATCH Celiac Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037516
Enrollment
80
Registered
2025-07-23
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K90.0

Interventions

Group 1: Face2face Medical Nutrition Therapy in CeD Group 2: 30minute PowerPoint-based video on nutritional advice for CeD

Sponsors

Charité - Universitätsmedizin Berlin, Klinik für Gastroenterologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Established diagnosis of CeD Initial CeD diagnosis >1 year ago

Exclusion criteria

Exclusion criteria: Change of a celiac disease-relevant therapy within the last 6 weeks Does not understand informed consent or cannot sign informed consent Insufficient German language skills

Design outcomes

Primary

MeasureTime frame
Overall well-being is the primary endpoint of this study and is determined using a visual analog scale (VAS 100 mm). For this purpose, the study participant marks the location of the VAS line on the study questionnaire, which most adequately corresponds to a self-assessed quantification of her/his well-being.

Secondary

MeasureTime frame
Total score of NutriMATCH-CeD questionnaire Symptoms Adaptation of diet Body weight and dynamics of body weight Impact of diet on daily life (nutrition-related distress) Food-related QoL Self-assessment of state of health Expectations of nutritional therapy

Countries

Germany

Contacts

Public ContactMichael Schumann

Charité - Universitätsmedizin Berlin, Klinik für Gastroenterologie

michael.schumann@charite.de49030450514322

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026